144 institutions hold shares in NextCure Inc. (NXTC), with 3.66M shares held by insiders accounting for 13.27% while institutional investors hold 83.51% of the company’s shares. The shares outstanding are 27.56M, and float is at 23.59M with Short Float at 6.23%. Institutions hold 72.42% of the Float.
The top institutional shareholder in the company is Orbimed Advisors LLC. with over 2.71 million shares valued at $29.55 million. The investor’s holdings represent 9.82% of the NXTC Shares outstanding. As of Dec 30, 2020, the second largest holder is Sofinnova Investments, Inc. with 2.67 million shares valued at $29.12 million to account for 9.68% of the shares outstanding. The other top investors are Morgan Stanley which holds 2.18 million shares representing 7.90% and valued at over $23.78 million, while Blackrock Inc. holds 5.49% of the shares totaling 1.51 million with a market value of $16.51 million.
NextCure Inc. (NASDAQ: NXTC) is -16.88% lower on its value in year-to-date trading and has touched a low of $7.91 and a high of $39.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NXTC stock was last observed hovering at around $9.25 in the last trading session, with the day’s loss setting it -0.19% off its average median price target of $17.00 for the next 12 months. It is also 69.8% off the consensus price target high of $30.00 offered by 8 analysts, but current levels are 9.4% higher than the price target low of $10.00 for the same period.
Currently trading at $9.06, the stock is -5.69% and -17.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.24 million and changing -2.05% at the moment leaves the stock -14.43% off its SMA200. NXTC registered -74.36% loss for a year compared to 6-month loss of -17.11%. The firm has a 50-day simple moving average (SMA 50) of $11.67 and a 200-day simple moving average (SMA200) of $11.21.
The stock witnessed a -9.13% gain in the last 1 month and extending the period to 3 months gives it a -25.77%, and is -0.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.65% over the week and 5.22% over the month.
NextCure Inc. (NXTC) has around 90 employees, a market worth around $256.31M and $22.40M in sales. Distance from 52-week low is 14.54% and -77.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.90%).
NextCure Inc. (NXTC) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for NextCure Inc. (NXTC) is a “Overweight”. 8 analysts offering their recommendations for the stock have an average rating of 2.40, where 3 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
NextCure Inc. is expected to release its quarterly report on 08/06/2021 and quarterly earnings per share for the current quarter are estimated at -$0.59.The EPS is expected to grow by 38.10% this year.
NextCure Inc. (NXTC) Insider Activity
A total of 0 insider transactions have happened at NextCure Inc. (NXTC) in the last six months, with sales accounting for 0 and purchases happening 0 times.